2016 annual financial data

BioCryst Pharmaceuticals 2016 Financial results

BioCryst Pharmaceuticals 2016 financial results with verified reported values.

Direct answer

Revenue was 26,353,000 USD.

Operating income was -48,607,000 USD and net income was -55,144,000 USD.
Operating cash flow was -53,438,000 USD.

Get free BioCryst Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
26,353,000 USD
Operating income
-48,607,000 USD
Net income
-55,144,000 USD
Operating cash flow
-53,438,000 USD